Literature DB >> 11507351

Increased acid-sensing ion channel ASIC-3 in inflamed human intestine.

Y Yiangou1, P Facer, J A Smith, L Sangameswaran, R Eglen, R Birch, C Knowles, N Williams, P Anand.   

Abstract

OBJECTIVES: Acid-sensing ion channels (ASICs) are expressed by rat sensory neurons and may mediate pain associated with tissue acidosis after inflammation or injury. Our aim was to examine the molecular forms and localization of ASICs in human intestine and dorsal root ganglia using immunochemical techniques, and to measure the effects of inflammation and injury. DESIGN AND METHODS: Inflamed Crohn's disease intestine and injured human dorsal root ganglia, with appropriate controls, were studied by Western blotting and immunohistochemistry, using specific affinity-purified ASIC antibodies.
RESULTS: In the Western blot, there was a significant three-fold increase in the mean relative optical density of the ASIC-3 55-kDa band (but not ASIC-1 or ASIC-2) in full-thickness inflamed intestine, as well as in separated muscle and mucosal layers. There was a corresponding trend for an increased immunoreactive density and increased number of ASIC-3-positive neurons in the myenteric and sub-mucous plexus of inflamed intestine. In dorsal root ganglia, immunoreactivity for all ASICs was restricted to a sub-population (about 50%) of small-diameter (nociceptor) sensory neurons, and was generally less intense after injury.
CONCLUSIONS: Increased ASIC-3 in inflamed intestine suggests a role in pain or dysmotility, for which ASICs represent new therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507351     DOI: 10.1097/00042737-200108000-00003

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  37 in total

Review 1.  Acid sensing by visceral afferent neurones.

Authors:  P Holzer
Journal:  Acta Physiol (Oxf)       Date:  2011-01       Impact factor: 6.311

2.  Synthesis, structure-activity relationship, and pharmacological profile of analogs of the ASIC-3 inhibitor A-317567.

Authors:  Scott D Kuduk; Christina N Di Marco; Vera Bodmer-Narkevitch; Sean P Cook; Matthew J Cato; Aneta Jovanovska; Mark O Urban; Michael Leitl; Nova Sain; Annie Liang; Robert H Spencer; Stefanie A Kane; George D Hartman; Mark T Bilodeau
Journal:  ACS Chem Neurosci       Date:  2009-10-06       Impact factor: 4.418

Review 3.  ENaCs and ASICs as therapeutic targets.

Authors:  Yawar J Qadri; Arun K Rooj; Catherine M Fuller
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

4.  Acid-sensing properties in rat gastric sensory neurons from normal and ulcerated stomach.

Authors:  Takeshi Sugiura; Khoa Dang; Kenneth Lamb; Klaus Bielefeldt; G F Gebhart
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

Review 5.  Pain and inflammatory bowel disease.

Authors:  Klaus Bielefeldt; Brian Davis; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

Review 6.  Understanding inflammatory pain: ion channels contributing to acute and chronic nociception.

Authors:  John E Linley; Kirstin Rose; Lezanne Ooi; Nikita Gamper
Journal:  Pflugers Arch       Date:  2010-02-17       Impact factor: 3.657

Review 7.  Ion channels as drug targets in central nervous system disorders.

Authors:  A M Waszkielewicz; A Gunia; N Szkaradek; K Słoczyńska; S Krupińska; H Marona
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 8.  Functional abdominal pain.

Authors:  P J Matthews; Q Aziz
Journal:  Postgrad Med J       Date:  2005-07       Impact factor: 2.401

9.  Functional properties and pharmacological inhibition of ASIC channels in the human SJ-RH30 skeletal muscle cell line.

Authors:  D P Gitterman; J Wilson; A D Randall
Journal:  J Physiol       Date:  2004-12-02       Impact factor: 5.182

Review 10.  Acid-sensing ion channels 3: a potential therapeutic target for pain treatment in arthritis.

Authors:  Feng-Lai Yuan; Fei-Hu Chen; Wei-Guo Lu; Xia Li
Journal:  Mol Biol Rep       Date:  2009-11-03       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.